Jun 20 |
Nutriband Provides Product Development Update for Its Lead Product Aversa Fentanyl
|
Jun 3 |
Nutriband Inc. Quarterly Report Emphasizes Focus on Kinesiology Tape Output as Q1 Sports Tape Revenues Increase 219% Year Over Year
|
May 21 |
Join Nutriband's Exclusive Live Investor Webinar and Q&A Session on May 30
|
May 16 |
Nutriband Appoints Accomplished Business Leader Sergei Glinka to its Board of Directors
|
May 10 |
Can-Fite BioPharma and Nutriband Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
|
Apr 25 |
IBN Coverage Initiated for Nutriband Inc.
|
Apr 24 |
Nutriband Closes $8.4M Private Placement for Commercial Development of Aversa(R) Fentanyl Transdermal Patch Through FDA Submission
|
Apr 23 |
Nutriband signs exclusive supplier agreement with Fit for Life
|
Apr 23 |
Nutriband Inc. Signs Exclusive Supplier Agreement with Major Sports Brand Licensee Fit for Life Group
|
Mar 27 |
Nutriband Provides Clinical and Regulatory Path Overview for Lead Product - AVERSA(R) Fentanyl Transdermal Patch
|